Перегляд за автором "Nesina, I.P."

Сортувати за: Порядок: Результатів:

  • Buchynska, L.G.; Nesina, I.P.; Yurchenko, N.P.; Bilyk, O.O.; Grinkevych, V.N.; Svintitsky, V.S. (Experimental Oncology, 2007)
    Aim: The analysis of p53, p21WAF1/CIP1, p16INK4a and Ki-67 expression in serous ovarian carcinomas of different grade. Materials and Methods: In total, 43 ovarian adenocarcinomas and 8 non-altered ovarian epithelial tissues ...
  • Buchynska, L.G.; Iurchenko, N.P.; Grinkevych, V.M.; Nesina, I.P.; Chekhun, S.V.; Svintsitsky, V.S. (Experimental Oncology, 2009)
    Aim: To study the expression of estrogen receptors (ER) and progesterone receptors (PR) and proliferation marker Ki-67 in ovarian tumors using immunohistochemistry, and evaluate possible prognostic significance ofthese ...
  • Nesina, I.P.; Iurchenko, N.P.; Buchynska, L.G. (Experimental Oncology, 2018)
    Aim: To study the expression of adhesion markers (E-cadherin, β-catenin and vimentin) associated with epithelial-mesenchymal transition (EMT) and their role in progression of endometrial carcinoma (EC). Materials and ...
  • Buchynska, L.G.; Lurchenko, N.P.; Glushchenko, N.M.; Nesina, I.P. (Experimental Oncology, 2017)
    Aim: To determine the peculiarities of expression of a number of proteins-regulators of the cell cycle in endometrial cancer (EC) cells in patients with a family history of oncological pathologies. Patients and Methods: ...
  • Glushchenko, N.M.; Nesina, I.P.; Lurchenko, N.P.; Proskurnya, L.A.; Buchynska, L.G. (Experimental Oncology, 2014)
    Aim: To create an information resource concerning multifactorial oncological diseases of the female reproductive system. Materials and Methods: A comprehensive search of the literature in the PubMed and Ukrainian scientific ...
  • Nesina, I.P.; Lurchenko, N.P.; Nespryadko, S.V.; Buchynska, L.G. (Experimental Oncology, 2014)
    Aim: Study is devoted to evaluation of sensitivity of peripheral blood T-lymphocytes (PBL) of patients with endometrial cancer (EC) to genotoxic effect of bleomycin and detection of patients with hidden chromosomal ...